(Q31148056)

29 June 2017

title

Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain (English)

1 reference

29 June 2017

Sandra Demaria

8

0 references

Luis Chiriboga

object named as

Luis Chiriboga

3

0 references

author name string

David Zagzag

1

1 reference

29 June 2017

Konstantin Salnikow

2

1 reference

29 June 2017

Herman Yee

4

1 reference

29 June 2017

Li Lan

5

1 reference

29 June 2017

M Aktar Ali

6

1 reference

29 June 2017

Roberto Garcia

7

1 reference

29 June 2017

Elizabeth W Newcomb

9

1 reference

29 June 2017

publication date

1 March 2005

1 reference

29 June 2017

published in

Laboratory Investigation

1 reference

29 June 2017

volume

85

1 reference

29 June 2017

issue

3

1 reference

29 June 2017

page(s)

328-341

1 reference

Isolation and characterization of human malignant glioma cells from histologically normal brain

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Malignant glioma: genetics and biology of a grave matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

BLAT—The BLAST-Like Alignment Tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Identifying differentially expressed genes in cDNA microarray experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Synthesis and secretion of alpha 2-macroglobulin by human glioma established cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

LGI1, a putative tumor metastasis suppressor gene, controls in vitro invasiveness and expression of matrix metalloproteinases in glioma cells through the ERK1/2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Glioma migration: clues from the biology of neural progenitor cells and embryonic CNS cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

The extracellular matrix of gliomas: modulation of cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Influence of PGE2- and cAMP-modulating agents on human glioblastoma cell killing by interleukin-2-activated lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Cytokines and immunoregulatory molecules in malignant glial neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Selective expression of interleukin-10 gene within glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Coexpression of interleukin-1 beta and interleukin-6 in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Substance P induces secretion of immunomodulatory cytokines by human astrocytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Human glioma immunobiology in vitro: implications for immunogene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

In vitro prostaglandin E2 production by glioblastoma cells and its effect on interleukin-2 activation of oncolytic lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Malignant glioma modulation of immune function: relative contribution of different soluble factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Inflammatory leukocytes associated with increased immunosuppression by glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Immune defects observed in patients with primary malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Microglial/macrophage expression of interleukin 10 in human glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

The expanding universe of T-cell subsets: Th1, Th2 and more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

MHC class I antigens, immune surveillance, and tumor immune escape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

HLA class I expression on human cancer cells. Implications for effective immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

The HLA crossroad in tumor immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Selective acceptance of MHC class I-deficient tumor grafts in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Malignant melanoma. Inflammatory mononuclear cell infiltrates in cerebral metastases during concurrent therapy with viral oncolysate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Basic principles of immunological surveillance of the normal central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

Green fluorescent protein immunohistochemistry as a novel experimental tool for the detection of glioma cell invasion in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

7 January 2021

Growth and migration markers of rat C6 glioma cells identified by serial analysis of gene expression

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

7 January 2021

In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

7 January 2021

The glioblastoma-derived T cell suppressor factor/transforming growth factor-beta 2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

7 January 2021

Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

7 January 2021

Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

7 January 2021

Systemic immunity against a murine colon tumor (CT-26) produced by immunization with syngeneic cells expressing a transfected viral gene product

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700233

7 January 2021

10.1038/LABINVEST.3700233

Identifiers

DOI

1 reference

Dimensions Publication ID

29 June 2017

1004921651

0 references

1 reference